CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition

Slides:



Advertisements
Similar presentations
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
Advertisements

Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
Nancy Briggs Kylie Hurst Stephen McDonald CHAPTER 4 METHOD AND LOCATION OF DIALYSIS 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand ANZDATA Registry Annual Report Chapter 12.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
Why don’t indigenous dialysis patients receive transplants – waitlist or allocation? N. Khanal 1, P. Clayton 1, S. McDonald 1, M. Jose 2 1 The University.
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN Annual Report—35th Edition ANZDATA Registry Annual Report.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
© ANZDATA Registry PEADIATRIC CHAPTER CHAPTER 11.
TRANSPLANTATION CHAPTER 8 ANZDATA Registry Annual Report 2013.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
Chapter 11 Paediatrics 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Paediatric.
Chapter 10 Cancer 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Cancer Working.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 3 Mortality in End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 6 Home Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
DEATHS CHAPTER 3. © ANZDATA Registry Figure 3.1 Survival among People who Commenced Dialysis 2001—2010 (Non-Indigenous) % (95% CI) Age at Start Time Period.
STOCK AND FLOW CHAPTER 1. © ANZDATA Registry Figure 1.1 Prevalent Patients (Number Per Million Population at 31st December)
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
© ANZDATA Registry Stock and Flow of CAPD Patients Australia Number of Patients 1504 Patients * (Data to 30 Sept) Extrapolated.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition DEATHS CHAPTER 3.
Figures from Dialysis and kidney transplantation in Australia 1991–2010.
Obesity in the end stage kidney disease population
Stephen P. McDonald, Graeme R. Russ  Kidney International 
UK Renal Registry 13th Annual Report
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
2016 Annual Data Report, Vol 2, ESRD, Ch 6
ASSOCIATION OF SOCIO-ECONOMIC POSITION WITH TECHNIQUE FAILURE AND MORTALITY IN AUSTRALIAN NON-INDIGENOUS PERITONEAL DIALYSIS PATIENTS Dr Samuel Chan Nephrology.
Australian Kidney Transplant Waiting List Stock and Flow
First-year death rates by modality figure 8
Prevalence (pmp) of Renal Replacement Therapy
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Fig 7.1 Median URR achieved in each renal unit
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
2013 Annual Report - 36th Edition
CHAPTER 5 Paediatric Renal Replacement Therapy
ANZDATA 2014 Annual Report Chapter 11
In Reply to ‘The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis’  Emily J. See, MBBS, David W. Johnson, PhD, Yeoungjee.
ANZDATA Registry Annual Report 2013
Fig 6.1 Frequency of ischaemic heart disease in incident patients
Volume 85, Issue 1, Pages (January 2014)
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
Stephen P. McDonald  Kidney International Supplements 
2013 Annual Report - 36th Edition
UK Renal Registry 14th Annual Report
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
UK Renal Registry 14th Annual Report
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Update from the Haemodialysis Working Group
Dialysis outcomes in Australia & New Zealand
Figure 3.1 Death Rates by States All Dialysis Patients
Demographic Characteristics of Cohort
ANZDATA: Vascular Access
Figure Prevalence of coronary artery disease by year or
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Stock and Flow of Haemodialysis Patients Australia
Presentation transcript:

CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012

Survival among People who Commenced Figure 3.1 Survival among People who Commenced Dialysis 2002—2011 (Non-Indigenous) % (95% CI) Age at Start Time Point (Number of Years from dialysis start) Proportion Surviving Aust (95 % CI) Proportion Surviving NZ (95 % CI) 0– 24 1 97 (95-98) 96 (90-98)   2 93 (90-96) 94 (86-97) 5 90 (85-93) 78 (56-90) 25—44 97 (96-97) 99 (97-100) 91 (90-92) 94 (90-96) 80 (78-83) 73 (64-80) 45—64 92 (91-92) 91 (89-92) 84 (83-85) 81 (78-83) 60 (58-61) 53 (49-58) 65—74 85 (84-86) 84 (81-87) 72 (71-74) 71 (67-75) 41 (39-42) 34 (29-38) 75—84 80 (79-81) 76 (72-80) 64 (62-65) 55 (50-60) 27 (25-28) 19 (14-24) 85 + 69 (65-73) 65 (46-78) 51 (46-55) 43 (26-59) 17 (13-22) 13 (3-31) ANZDATA Registry Annual Report 2012

(per 100 patient years, 95% CI) Figure 3.2 Death Rates During Renal Replacement Therapy All Patients Included who Received Treatment During 2011 Group Dialysis Mortality Rate (per 100 patient years, 95% CI) Transplant Overall Rate Confidence Intervals Confidence Intervals Per 100 patient years Lower Upper Australia 13.7 13.0 14.4 2.4 2.1 2.7 New Zealand 15.5 14.0 17.2 2.8 3.8 Ages (Years)   < 25 1.9 0.8 4.7 0.4 0.1 1.6 25—44 4.9 3.9 6.1 0.6 1.0 45—64 9.5 8.7 10.4 1.8 2.6 65—84 19.2 18.1 20.4 6.2 5.2 7.5 ≥ 85 35.8 30.8 41.6 48.7 20 ~ Diabetes (at RRT start) Non-diabetic 12.1 11.3 18.9 2.3 2.0 Type 1 16.9 13.1 21.9 1.7 4.5 Type 2 1.5 15.4 17.6 3.4 7.1 Coronary artery disease (at RRT start) No 10.7 10.0 11.4 2.2 Yes 20.1 21.4 3.5 6.8 Indigenous Non-Indigenous (Australia) 14.3 13.5 15.0 Non-Indigenous (New Zealand) 16.8 14.5 19.4 2.9 4.0 Aboriginal /Torres Strait Islanders 13.3 1.1 6.5 Maori (in Australia) 11.1 6.3 19.5 No events Maori (in New Zealand) 14.1 3.3 1.4 8.0 Pacific People (in Australia) 4.8 8.4 0.7 Pacific People (in New Zealand) ANZDATA Registry Annual Report 2012

ANZDATA Registry Annual Report 2012 Figure 3.3 ANZDATA Registry Annual Report 2012

ANZDATA Registry Annual Report 2012 Figure 3.4 ANZDATA Registry Annual Report 2012

Age Groups at start of treatment Figure 3.5 Survival of Dialysis Patients by age Age Groups at start of treatment Median (25th and 75th centiles), years   Australia 0-24 years * 25-44 years 9.26 (5.37-*) 45-64 years 6.26 (3.01-2.65) 65-74 years 4.10 (1.84-7.01) 75-84 years 2.97 (1.30-5.27) 85+ years 2.03 (0.73-3.97) New Zealand 9.64 (7.92-*) 7.28 (4.12-*) 4.97 (2.65-8.05) 3.59 (1.81-5.93) 2.51 (1.07-4.26) 1.69 (0.96-3.58) ANZDATA Registry Annual Report 2012

Survival by Age & Comorbidity amongst older age groups Figure 3.6 Survival by Age & Comorbidity amongst older age groups Median (25th and 75th centiles), years Age Groups Any Vascular Disease Diabetes Australia   New Zealand 65-69 years No 5.32 (2.04 -) 6.01 (2.67-7.68) Yes 3.95 (1.93-8.29) 5.23 (4.20-8.69) 4.30 (2.08-7.04) 2.36 (0.87-4.81) 4.31 (1.41-6.96) 4.03 (1.41-4.27) 70-74 years 5.89 (3.24-8.38) 3.33 (2.27-4.41) 5.59 (2.39- ) 3.92 (3.92-4.39)* 3,46 (0.96-5.81) 2.55 (1.63-4.45) 3.65 (1.80-4.97) 3.33 (1.78-4.88) 75-79 years 5.47 (2.14-8.31) 3.43 (3.43-3.43)* 4.00 (1.85-6.35) 1.42 (0.57-2.43) 3.08 (1.04-5.48) 2.97 (1.49-5.74) 80-84 years 3.41 (2.02-6.41) 2.69 (1.65-3.09) 4.34 (2.70-6.17) 0.67 (0.67-0.67)* 2.28(1.09-4.90) 2.82 (2.82-2.82)* 2.37 (1.29-4.55) 2.82 )2.82-2.82)* 85-89 years 2.25 (0.63-7.79) * 2.39 (0.63-) 2.17 (1.32-3.58) 1.38 (1.38-4.91)* 1.57 (0.37-6.09) ANZDATA Registry Annual Report 2012

ANZDATA Registry Annual Report 2012 Figure 3.7 Australia ANZDATA Registry Annual Report 2012

ANZDATA Registry Annual Report 2012 Figure 3.8 New Zealand ANZDATA Registry Annual Report 2012

ANZDATA Registry Annual Report 2012 Figure 3.9 ANZDATA Registry Annual Report 2012

ANZDATA Registry Annual Report 2012 Figure 3.10 ANZDATA Registry Annual Report 2012

Modality at time of death and age at death –2011 Figure 3.11 Modality at time of death and age at death –2011 Cause of Death Haemodialysis   Peritoneal Dialysis Transplant 0 - 44 45 - 64 65 - 74 ≥75 Australia Cardiovascular 16 117 92 159 2 24 39 32 5 19 7 Withdrawal 15 61 110 229 3 13 18 36 4 Cancer 30 29 6 31 27 8 Infection 40 44 54 20 9 Other 17 56 53 74 12 21 10 New Zealand 45 26 1 11 14 ANZDATA Registry Annual Report 2012

Country at time of death and Modality at death among those Figure 3.12 Country at time of death and Modality at death among those who withdrew from dialysis and died in 2011 Cause of Death AUSTRALIA   NEW ZEALAND HD PD GRAFT Cardiovascular 384 97 42 84 49 9 Withdrawal 415 70 10 66 36 5 Cancer 76 16 6 Infection 144 24 38 35 18 7 Other 200 50 40 39 30 13 ANZDATA Registry Annual Report 2012

Death due to withdrawal-2011 (Modality at time of death) Figure 3.13 Death due to withdrawal-2011 (Modality at time of death) Withdrawal Haemodialysis Peritoneal Dialysis Transplant Total Australia   Psychosocial 177 31 6 214 Patient refused further 2 Suicide 1 Cardiovascular comorbidity 75 13 89 Cerebrovascular comorbidity 36 42 Peripheral vascular comorbidity 24 8 33 Malignancy related withdrawal 82 7 91 Withdrawal due to dialysis 19 4 23 415 70 10 495 New Zealand 11 37 17 9 27 5 3 18 15 66 107 ANZDATA Registry Annual Report 2012

Dialysis patients who withdrew by age at death Figure 3.14 Dialysis patients who withdrew by age at death time from first RRT-2011 Time from first RRT AUSTRALIA   NEW ZEALAND 0 - 44 45 - 64 65 - 74 ≥75 Total 3 13 31 30 77 0  1    8   12 1 7 34 57 4    4   2 10 6 25 45 96 172 5    17   16 38 5 32 42 109 189 2   12   14   19 47 18 131 269 495 2  22   43   40 107 ANZDATA Registry Annual Report 2012

ANZDATA Registry Annual Report 2012 Figure 3.15 ANZDATA Registry Annual Report 2012

ANZDATA Registry Annual Report 2012 Figure 3.16 ANZDATA Registry Annual Report 2012